Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1351-1360 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|April 22, 2008
Epigenetic regulator polycomb group protein complexes control cell fate and cancerRieko Kanno, Harinarayanan Janakiraman, Masamoto Kanno
Cancer Science|April 22, 2008
Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicityMasayasu Hara, Hayao Nakanishi, Kunio Tsujimura, et al.
Cancer Science|April 24, 2008
Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 modelWei Fu, Hekui Lan, Shenghua Liang, et al.
Cancer Science|April 24, 2008
Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumorYohei Saito, Masahiro Yasunaga, Junichiro Kuroda, et al.
Cancer Science|October 16, 2016
miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cellsJing Song, Yue Li
Cancer Science|October 7, 2016
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210GKohei Shitara, Kimio Yonesaka, Tadamichi Denda, et al.
Cancer Science|December 14, 2016
Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activitiesMakoto Ibata, Junko Iwasaki, Yoichiro Fujioka, et al.
Cancer Science|October 12, 2016
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patientsRin Ogiya, Naoki Niikura, Nobue Kumaki, et al.
Cancer Science|October 12, 2016
Potential capacity of endoscopic screening for gastric cancer in JapanChisato Hamashima, Rei Goto
Cancer Science|September 30, 2016
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabineMasafumi Ikeda, Akihiro Sato, Nobuo Mochizuki, et al.
Pageof 695

Showing results (1351-1360 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|April 22, 2008
Epigenetic regulator polycomb group protein complexes control cell fate and cancerRieko Kanno, Harinarayanan Janakiraman, Masamoto Kanno
Cancer Science|April 22, 2008
Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicityMasayasu Hara, Hayao Nakanishi, Kunio Tsujimura, et al.
Cancer Science|April 24, 2008
Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 modelWei Fu, Hekui Lan, Shenghua Liang, et al.
Cancer Science|April 24, 2008
Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumorYohei Saito, Masahiro Yasunaga, Junichiro Kuroda, et al.
Cancer Science|October 16, 2016
miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cellsJing Song, Yue Li
Cancer Science|October 7, 2016
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210GKohei Shitara, Kimio Yonesaka, Tadamichi Denda, et al.
Cancer Science|December 14, 2016
Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activitiesMakoto Ibata, Junko Iwasaki, Yoichiro Fujioka, et al.
Cancer Science|October 12, 2016
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patientsRin Ogiya, Naoki Niikura, Nobue Kumaki, et al.
Cancer Science|October 12, 2016
Potential capacity of endoscopic screening for gastric cancer in JapanChisato Hamashima, Rei Goto
Cancer Science|September 30, 2016
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabineMasafumi Ikeda, Akihiro Sato, Nobuo Mochizuki, et al.
Pageof 695